In December, the Phase 3 results for Corlux for the treatment of Cushing’s Syndrome are due out and investors have been showing an appetite for the stock as of late.
Read more ...Posts Tagged ‘CORT’
December Will Be Exciting for Up and Coming Corcept Pharmaceuticals
Written by Sheff
Monday, 29 November 2010 22:22
No Comments
Monday, 29 November 2010 22:22
No Comments
